Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2025
Sperm and offspring production in a nonobstructive azoospermia mouse model via testicular mRNA delivery using lipid nanoparticlesDaisuke Mashiko, Chihiro Emori, Yuki Hatanaka, et al.
Andrology|April 23, 2025
The absence of both RIBC1 and RIBC2 induces decreased sperm motility and litter size in male miceKento Katsuma, Keisuke Shimada, Shingo Tonai, et al.
Andrology|December 4, 2022
Generation of humanized LDHC knock-in mice as a tool to assess human LDHC-targeting contraceptive drugsRie Iida-Norita, Haruhiko Miyata, Yuki Kaneda, et al.
Biology of Reproduction|May 21, 2020
CIB4 is essential for the haploid phase of spermatogenesis in mice†Zoulan Xu, Haruhiko Miyata, Yuki Kaneda, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2021
SPATA33 localizes calcineurin to the mitochondria and regulates sperm motility in miceHaruhiko Miyata, Seiya Oura, Akane Morohoshi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2025
TEX38 localizes ZDHHC19 to the plasma membrane and regulates sperm head morphogenesis in miceYuki Kaneda, Yonggang Lu, Jiang Sun, et al.
Plos One|September 22, 2022
Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysisKoichiro Inaki, Tomoko Shibutani, Naoyuki Maeda, et al.
International Journal of Clinical Oncology|February 12, 2025
Human epidermal growth factor receptor 3 expression in patients with epithelial ovarian cancer: a potential target for ovarian mucinous and clear cell carcinomaSho Sato, Daisuke Shintani, Yuki Kaneda, et al.
Molecular Cancer Therapeutics|January 11, 2024
Raludotatug Deruxtecan, a CDH6-Targeting Antibody-Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer ModelsHirokazu Suzuki, Shotaro Nagase, Chiemi Saito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient InternalizationYuuri Hashimoto, Kumiko Koyama, Yasuki Kamai, et al.
Pageof 2